166 related articles for article (PubMed ID: 36522277)
21. The Precision Oncology Program for Cancer of the Prostate (POPCaP) Network: A Veterans Affairs/Prostate Cancer Foundation Collaboration.
Montgomery B; Rettig M; Kasten J; Muralidhar S; Myrie K; Ramoni R
Fed Pract; 2020 Aug; 37(Suppl 4):S48-S53. PubMed ID: 32908353
[TBL] [Abstract][Full Text] [Related]
22. Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer.
Deville C; Kamran SC; Morgan SC; Yamoah K; Vapiwala N
Pract Radiat Oncol; 2024; 14(1):47-56. PubMed ID: 38182303
[TBL] [Abstract][Full Text] [Related]
23. American Brachytherapy Society radiation oncology alternative payment model task force: Quality measures and metrics for brachytherapy.
Shah C; Vicini F; Beriwal S; Thaker N; Frank SJ; Rossi P; Orio P; Chang AJ; Joshi N; Campbell SR; Naghavi A; Chao S; Kamrava M; Deufel CL; Mourtada F; Suh JH
Brachytherapy; 2022; 21(1):63-74. PubMed ID: 34732290
[TBL] [Abstract][Full Text] [Related]
24. Comparing Quality of Care in Veterans Affairs and Non-Veterans Affairs Settings.
Anhang Price R; Sloss EM; Cefalu M; Farmer CM; Hussey PS
J Gen Intern Med; 2018 Oct; 33(10):1631-1638. PubMed ID: 29696561
[TBL] [Abstract][Full Text] [Related]
25. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.
Vora SA; Wong WW; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
J Urol; 2013 Aug; 190(2):521-6. PubMed ID: 23415964
[TBL] [Abstract][Full Text] [Related]
26. American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology.
Mayo CS; Moran JM; Bosch W; Xiao Y; McNutt T; Popple R; Michalski J; Feng M; Marks LB; Fuller CD; Yorke E; Palta J; Gabriel PE; Molineu A; Matuszak MM; Covington E; Masi K; Richardson SL; Ritter T; Morgas T; Flampouri S; Santanam L; Moore JA; Purdie TG; Miller RC; Hurkmans C; Adams J; Jackie Wu QR; Fox CJ; Siochi RA; Brown NL; Verbakel W; Archambault Y; Chmura SJ; Dekker AL; Eagle DG; Fitzgerald TJ; Hong T; Kapoor R; Lansing B; Jolly S; Napolitano ME; Percy J; Rose MS; Siddiqui S; Schadt C; Simon WE; Straube WL; St James ST; Ulin K; Yom SS; Yock TI
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1057-1066. PubMed ID: 29485047
[TBL] [Abstract][Full Text] [Related]
27. Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry.
Efstathiou JA; Nassif DS; McNutt TR; Bogardus CB; Bosch W; Carlin J; Chen RC; Chou H; Eggert D; Fraass BA; Goldwein J; Hoffman KE; Hotz K; Hunt M; Kessler M; Lawton CA; Mayo C; Michalski JM; Mutic S; Potters L; Rose CM; Sandler HM; Sharp G; Tomé W; Tran PT; Wall T; Zietman AL; Gabriel PE; Bekelman JE
J Oncol Pract; 2013 May; 9(3):e90-5. PubMed ID: 23942508
[TBL] [Abstract][Full Text] [Related]
28. Clinical dashboard development and use for academic detailing in the U.S. Department of Veterans Affairs.
Lau MK; Bounthavong M; Kay CL; Harvey MA; Christopher MLD
J Am Pharm Assoc (2003); 2019; 59(2S):S96-S103.e3. PubMed ID: 30713078
[TBL] [Abstract][Full Text] [Related]
29. Assessing fidelity of cognitive behavioral therapy in rural VA clinics: design of a randomized implementation effectiveness (hybrid type III) trial.
Cucciare MA; Curran GM; Craske MG; Abraham T; McCarthur MB; Marchant-Miros K; Lindsay JA; Kauth MR; Landes SJ; Sullivan G
Implement Sci; 2016 May; 11():65. PubMed ID: 27164866
[TBL] [Abstract][Full Text] [Related]
30. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I
J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629
[TBL] [Abstract][Full Text] [Related]
31. Quality Improvements of Veterans Health Administration Radiation Oncology Services Through Partnership for Accreditation With the ACR.
Kapoor R; Moghanaki D; Rexrode S; Monzon B; Ray M; Hulick PR; Albuquerque K; Rosenthal SA; Palta JR; Hagan MP
J Am Coll Radiol; 2018 Dec; 15(12):1732-1737. PubMed ID: 30100162
[TBL] [Abstract][Full Text] [Related]
32. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
33. Demographic Differences Among US Department of Veterans Affairs Patients Referred for Genetic Consultation to a Centralized VA Telehealth Program, VA Medical Centers, or the Community.
Scheuner MT; Huynh AK; Chanfreau-Coffinier C; Lerner B; Gable AR; Lee M; Simon A; Coeshott R; Hamilton AB; Patterson OV; DuVall S; Russell MM
JAMA Netw Open; 2022 Apr; 5(4):e226687. PubMed ID: 35404460
[TBL] [Abstract][Full Text] [Related]
34. Oncology management by the "new" Veterans Health Administration.
Wilson NJ; Kizer KW
Cancer; 1998 May; 82(10 Suppl):2003-9. PubMed ID: 9587098
[TBL] [Abstract][Full Text] [Related]
35. Systematic review: comparison of the quality of medical care in Veterans Affairs and non-Veterans Affairs settings.
Trivedi AN; Matula S; Miake-Lye I; Glassman PA; Shekelle P; Asch S
Med Care; 2011 Jan; 49(1):76-88. PubMed ID: 20966778
[TBL] [Abstract][Full Text] [Related]
36. Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
Cooperberg M; Lubeck DP; Penson D; Mehta SS; Carroll PR; Kane CJ
J Urol; 2003 Sep; 170(3):905-8. PubMed ID: 12913727
[TBL] [Abstract][Full Text] [Related]
37. Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.
Gómez Caamaño A; Zapatero A; López Torrecilla J; Maldonado X
Clin Transl Oncol; 2016 Sep; 18(9):884-92. PubMed ID: 26621508
[TBL] [Abstract][Full Text] [Related]
38. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
Bruynzeel AME; Tetar SU; Oei SS; Senan S; Haasbeek CJA; Spoelstra FOB; Piet AHM; Meijnen P; Bakker van der Jagt MAB; Fraikin T; Slotman BJ; van Moorselaar RJA; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1086-1094. PubMed ID: 31419510
[TBL] [Abstract][Full Text] [Related]
39. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
